US2002102613A1PendingUtilityA1

Novel Fab fragment libraries and methods for their use

Priority: May 18, 1999Filed: Nov 19, 2001Published: Aug 1, 2002
Est. expiryMay 18, 2019(expired)· nominal 20-yr term from priority
C40B 50/06C07K 16/18C07K 16/00C07K 2317/55C07K 16/26
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides Fab libraries and methods for using the Fab libraries to obtain antibodies against a target. The Fab library of the invention contains at least 10 9 different Fabs, and in some embodiments, at least 10 10 different Fabs. The Fab libraries of the invention are used to isolate polyclonal or monoclonal Fabs that bind with high specificity to targets.

Claims

exact text as granted — not AI-modified
1 . A plurality of polynucleotides encoding a Fab library comprising a plurality of vector wherein the vector comprises: 
 a first and second cloning region, wherein 
 each cloning region comprises at least one, for the vector unique, restriction enzyme cleavage site,  
 each cloning region being 5′ flanked by a ribosome binding site and a signal sequence,  
   a polynucleotide encoding an anchor region, located 3′ of the second cloning region,    a first and a second plurality of variable polynucleotides, 
 each encoding a complete antibody variable region or part of an antibody variable region, possibly followed by a complete antibody constant region or part of an antibody constant region,  
 the first plurality of variable polynucleotides being cloned into the vector at the restriction enzyme cleavage site(s) of the first cloning region,  
 the second plurality of variable polynucleotides being cloned into the vector at the restriction enzyme cleavage site(s) of the second cloning region.  
   
     
     
         2 . Polynucleotide according to  claim 1 , wherein the first plurality of variable polynucleotides are V L  polynucleotides, and the second plurality of variable polynuclotides are V H  polynucleotides.  
     
     
         3 . Polynucleotides according to any of the preceding claims, wherein the polynucleotides encode at least 10 9  different Fabs, preferably at least 10 10  different Fabs, most preferably at least 3.7×10 10  different Fabs.  
     
     
         4 . Fab library, comprising: 
 a plurality of vectors, wherein the vector comprises:    a first and a second cloning region, wherein 
 each cloning region comprises at least one, for the vector unique, restriction enzyme cleavage site,  
 each cloning region being 5′ flanked by a ribosome binding site and a signal sequence,  
   a polynucleotide encoding an anchor region, located 3′ of the second cloning region,    a first and a second plurality of variable polynucleotides, 
 each encoding a complete antibody variable region or part of an antibody variable region, possibly followed by a complete antibody constant region or part of an antibody constant region,  
 the first plurality of variable polynucleotides being cloned into the vector at the restriction enzyme cleavage site(s) of the first cloning region,  
 the second plurality of variable polynucleotides being cloned into the vector at the restriction enzyme cleavage site(s) of the second cloning region to form a plurality of fusion polynucleotides encoding a plurality of fusion proteins,  
   a plurality of capsid particles, wherein the plurality of vector containing the first and second pluralities of variable polynucleotides is packaged into the capsid particles, wherein 
 at least some of the capsid particles display the fusion protein encoded by the vector packaged into the capsid on the surface of the capsid.  
   
     
     
         5 . Method of making a plurality of polynucleotides encoding a Fab library, comprising the steps of: 
 amplifying a first plurality of variable polynucleotides with a first set of primers,    amplifying a second plurality of variable polynucleotides with a second set of primers, 
 wherein each set of primers comprises oligonucleotides designed to be homologous to the 5′ and 3′ end of variable polynucleotides encoding antibody variable regions or parts thereof, such that they can be used to amplify variable polynucleotide pools from natural or synthetic sources of genes while retaining all or part of the antibody's antigen combining site;  
   cloning the first and second plurality of variable polynucleotides into a plurality of vectors, 
 wherein the vector comprises: 
 a first and a second cloning region, wherein 
 each cloning region comprises at least one, for the vector unique, restriction enzyme cleavage site,  
 each cloning region being 5′ flanked by a ribosome binding site and a signal sequence,  
 
 a polynucleotide encoding an anchor region, located 3′ of the second cloning region,  
 
 wherein the first plurality of variable polynucleotides is cloned into the restriction enzyme cleavage site(s) of the first cloning region of the vector and the second plurality of variable polynucleotides into the restriction enzyme cleavage site(s) of the second cloning region of the vector.  
   
     
     
         6 . Method according to  claim 5 , further comprising the steps of: 
 cloning the second plurality of variable polynucleotides into a plurality of another vector, and excising the variable polynucleotides from the vector with a restriction enzyme.    
     
     
         7 . Method of making a Fab library, wherein the plurality of vector containing the first and second pluralities of variable polynucleotides, obtained according to  claim 4  or  5 , are packaged into a plurality of capsid particles.  
     
     
         8 . Method for obtaining a Fab clone with specificity to a target, comprising the steps of: 
 obtaining a library of  claim 4 , and 
 selecting an antigen-binding Fab using in vitro selection on immobilised or labeled antigen.  
   
     
     
         9 . Monoclonal Fab or polyclonal collection of Fab clones comprising 
 one clone, respectively a plurality of clones obtained from a library of  claim 4  that specifically bind(s) to the human glycoprotein polymorphic epithelial Mucin-1 (MUC1).    
     
     
         10 . Vector as defined in any of the claims  1 - 3 .

Join the waitlist — get patent alerts

Track US2002102613A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.